Future of the Contraceptives Market: Trends, Innovations, and Key Forecasts Through 2034

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Contraceptives Market Size Growth Forecast: What to Expect by 2025?
The market size for contraceptives has seen robust growth in the past few years. This market is projected to expand from $27.92 billion in 2024 to $29.74 billion in 2025, with a compound annual growth rate (CAGR) of 6.5%. This growth during the historic period is due to factors such as the introduction of birth control pills, heightened awareness and knowledge about contraception, legal and social reforms that encourage reproductive rights, worldwide efforts to control population growth, and a rise in the usage of generic and low-priced drugs and devices.

How Will the Contraceptives Market Size Evolve and Grow by 2029?
In the ensuing years, the contraceptives market is predicted to experience robust growth, projected to reach $40 billion by 2029, with a compound annual growth rate (CAGR) of 7.7%. Factors contributing to this growth in the forecast period include the increased emphasis on male contraceptives, expanded contraception availability in developing countries, the fusion of digital health technologies with contraceptive measures, a surge in the demand for long-acting reversible contraceptives (LARCs), along with easier access to over-the-counter medications via online platforms. Major emerging trends anticipated within the forecast period comprise advancements in contraceptive technology, a transition towards non-hormonal and natural contraceptive methods, widening access to over-the-counter contraceptives, the accentuation on user-friendly and discreet contraceptive choices, and the incorporation of telemedicine within contraceptive advice and prescriptions.

View the full report here:
https://www.thebusinessresearchcompany.com/report/contraceptives-global-market-report

What Drivers Are Propelling the Growth of Contraceptives Market Forward?
The escalating incidence of sexually transmitted infections (STIs) is fueling the need for contraceptives. Sexually transmitted diseases, also referred to as infections, are disseminated from one individual to another via sexual contact. These infections most commonly spread during oral, anal, and vaginal sex but can also be passed on through other forms of close physical interaction. Contraceptives play a key role in controlling the spread of STIs like herpes and HPV, which primarily spread through direct skin contact. For example, the Minnesota Department of Health, a state health agency based in the U.S., has reported that primary and secondary syphilis cases surged by 19% in 2022 - from 564 in 2021 to 676. Additionally, 20 cases of congenital syphilis in infants were reported in 2022, marking a 42% increase from 2021, when only 14 cases were registered. Hence, the surge in STIs is anticipated to escalate demand for contraceptives in the upcoming years.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6920&type=smp

What Are the Key Trends Driving Contraceptives Market Growth?
Leading corporations in the contraceptives market are focusing their efforts on creating revolutionary birth control methods such as the Single Rod Subdermal Implant and the Subcutaneous Injectable Contraceptives to boost user comfort, ensure greater effectiveness, and offer long-lasting options for birth control. The goal of these progressions is to lessen the requirements for regular dosing, augment accessibility, and decrease potential side effects, thus providing more trustworthy and unnoticeable birth control options for those striving for superior reproductive health management. For example, in October 2023, the Health and Family Welfare Ministry, a government entity based in India, introduced two new methods of the Single Rod Subdermal Implant and Subcutaneous Injectable Contraceptive with an aim to enrich family planning services. These techniques are integral to the National Family Planning Programme and are developed to enhance maternal and newborn health results. The rollout of these contraceptives is designed to decrease maternal and infant sickness rates and death rates by providing an expanded range of family planning options. This initiative encapsulates a wider plan to improve reproductive health facilities in Karnataka, assuring that females have the availability of safe and potent contraceptive methods.

What Are the Key Segments in the Contraceptives Market?
The contraceptives market covered in this report is segmented -

1) By Product: Oral Contraceptive Pills, Topical Contraceptives, Injectables, Diaphragms, Vaginal Rings, s, Contraceptive Sponges, Subdermal Implants, Intra-Uterine Devices
2) By Age Group: 15-24 Years, 25-34 Years, 35-44 Years, 44 Years
3) By Distribution Channel: Hospital Pharmacies, Independent Pharmacies, Online Pharmacies, Clinics, Other Distribution Channels

Subsegments:
1) By Oral Contraceptive Pills: Combination Pills, Progestin-Only Pills
2) By Topical Contraceptives: Transdermal Patches, Gel Applications
3) By Injectables: Hormonal Injectables, Non-Hormonal Injectables
4) By Diaphragms: Silicone Diaphragms, Latex Diaphragms
5) By Vaginal Rings: Hormonal Rings, Non-Hormonal Rings
6) By s: Male s, Female s
7) By Contraceptive Sponges: Non-Hormonal Sponges, Hormonal Sponges
8) By Subdermal Implants: Hormonal Implants, Non-Hormonal Implants
9) By Intra-Uterine Devices (IUDs): Hormonal IUDs, Copper IUDs

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=6920&type=smp

Who Are the Key Players Shaping the Contraceptives Market's Competitive Landscape?
Major companies operating in the contraceptives market include Merck & Co. Inc., Bayer AG, Co. Inc., Cipla Inc., Reckitt Benckiser Group plc, Agile Therapeutics Inc., Allergan Ltd., Aurobindo Pharma Limited, Famy Care Ltd., Glenmark Pharmaceuticals Limited, HLL Lifecare Limited, Johnson & Johnson, Laboratoire HRA Pharma SAS, Lupin Limited, Mankind Pharma Ltd., Mayer Laboratories Inc., Medisafe Distribution Inc., Mithra Pharmaceuticals SA, Mylan NV, Okamoto Industries Inc., Pfizer Inc., Pregna International Ltd., Syncom Pharmaceuticals, Teva Pharmaceutical Industries Ltd., The Population Council, Veru Inc., Zydus Cadila, Shanghai Dahua Pharmaceutical Co. Ltd., Sichuan Kangdi Pharmaceutical Co. Ltd., Beijing Zhengyuan Pharmaceutical Co. Ltd., Zhejiang Huahai Pharmaceutical Co. Ltd., Chongqing Pharmaceutical Group Co. Ltd.

What Geographic Markets Are Powering Growth in the Contraceptives Market?
North America was the largest region in the contraceptives market in 2024 and is expected to be the fastest-growing region in the forecast period. The regions covered in the contraceptives market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6920

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795,
Asia +44 7882 955267 & +91 8897263534,
Europe +44 7882 955267
Email: saumyas@tbrc.info
The Business Research Company - www.thebusinessresearchcompany.com

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.